Health
Remyelinating drug shows potential to improve vision in patients with MS – News-Medical.Net
A team led by a biomedical scientist at the University of California, Riverside, reports a drug — an estrogen receptor ligand called indazole chloride (IndCl)…
A team led by a biomedical scientist at the University of California, Riverside, reports a drug — an estrogen receptor ligand called indazole chloride (IndCl) — has the potential to improve vision in patients with multiple sclerosis, or MS.
The study, performed on mice induced with a model of MS and the first to investigate IndCl’s effect on the pathology and function of the complete afferent visual pathway, is published in Brain Pathology. The afferent visual pathway includes the eyes, optic…
-
Noosa News15 hours agoForum responds to urgent homelessness issues in Nambour
-
Noosa News13 hours agoQueensland weather forecast sees sunny weather for last week of winter
-
Noosa News11 hours agoVisiting judges to join Qld Court of Appeal – Proctor
-
General14 hours agoEnergy provider ENGIE to ‘correct’ electricity bills for thousands of South Australian customers